Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Weight Loss Up to ~21% reduction Sustained at 72 weeks Beats GLP-1 alone Glycemic Control Lower HbA1c Steadier blood sugar GIP boosts response Cardiometabolic Lower blood pressure Better lipid panel Trial signals on CV Appetite Control Quieter cravings Smaller portions Less food noise Lose more weight on your terms
Some patients use tirzepatide strategicallycontinuing through a critical weight-loss window, then discontinuing once they've learned sustainable eating habits and established exercise routines
Information for healthcare professionals The GLP-1 receptor agonists Bydureon, Byetta, Lyxumia, Ozempic, Rybelsus, Trulicity and Victoza are indicated for diabetes only, Saxenda and Wegovy are indicated for weight management as an adjunct to diet and exercise in people who have obesity or overweight with weight-related health issues
For example, at $149 monthly for semaglutide, HSA savings could exceed $400-$500 annually in combined federal, state, and FICA tax reductions
Semaglutide Research Overview Semaglutide is a synthetic version of GLP-1, which plays a key role in regulating blood sugar levels and appetite
